Immunitor Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Immunitor General Information


Manufacturer and developer of immunotherapies and therapeutic vaccines intended for tuberculosis. The company is engaged in the development and manufacturing of oral vaccines for human immunodeficiency virus, hepatitis B and C, influenza, tuberculosis, broad-spectrum bacterial, cancer, obesity and fungal infections, enabling its clients to avail immunotherapies for a number of serious diseases affecting the world.

Contact Information

Ownership Status
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Parent Company
Immune Network
Corporate Office
  • 2906 West Broadway
  • Suite 365
  • Vancouver, British Columbia
  • Canada
+1 (360) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Immunitor Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Immunitor‘s full profile, request access.

Request a free trial

Immunitor Comparisons

HQ Location
Total Raised
Post Valuation
Manufacturer and developer of immunotherapies and therapeutic vaccines intended for tuberculosis. The company is engaged
Vancouver, Canada
00.000 0000-00-00


um dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proide
Pasadena, CA
000 As of 0000
00000000 00.000


rcitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute iru
0000 000000000
Carlsbad, CA
000 As of 0000
00.000 0000-00-00
00000000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Immunitor Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Arrowhead Pharmaceuticals Corporation Pasadena, CA 000 00.000 00000000 00.000
Ionis Pharmaceuticals Corporate Backed or Acquired Carlsbad, CA 000 0000 00000000000 0000
Dicerna Pharmaceuticals Formerly VC-backed Lexington, MA 000 00000 000000&0 00000
Alnylam Pharmaceuticals Formerly VC-backed Cambridge, MA 0000 00.000 0000 00.000
Regulus Therapeutics Formerly VC-backed San Diego, CA 00 00000 000000000 00000
You’re viewing 5 of 8 competitors. Get the full list »

Immunitor Executive Team (1)

Name Title Board Seat Contact Info
Aldar Bourinbaiar Chief Executive Officer & Principal
To view Immunitor’s complete executive team members history, request access »

Immunitor FAQs

  • When was Immunitor founded?

    Immunitor was founded in 2000.

  • Who is the CEO of Immunitor?

    Aldar Bourinbaiar is the CEO of Immunitor.

  • Where is Immunitor headquartered?

    Immunitor is headquartered in Vancouver, Canada.

  • What industry is Immunitor in?

    Immunitor’s primary industry is Pharmaceuticals.

  • Is Immunitor a private or public company?

    Immunitor is a Private company.

  • What is the current valuation of Immunitor?

    The current valuation of Immunitor is 00.000.

  • What is Immunitor’s current revenue?

    The current revenue for Immunitor is 00000.

  • Who are Immunitor’s competitors?

    Arrowhead Pharmaceuticals, Ionis Pharmaceuticals, Dicerna Pharmaceuticals, Alnylam Pharmaceuticals, and Regulus Therapeutics are some of the 8 competitors of Immunitor.

  • When was Immunitor acquired?

    Immunitor was acquired on 14-Feb-2011.

  • Who acquired Immunitor?

    Immunitor was acquired by Immune Network.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »